Launch of Stellar Product
In September, Accuray launched the Stellar product at ASTRO, representing a commitment to adaptive radiotherapy and precision care, receiving positive reception and strong interest from existing and new customers.
Memorandum of Understanding with University of Wisconsin
Accuray signed a memorandum of understanding with the University of Wisconsin School of Medicine and Public Health to advance online adaptive radiotherapy, focusing on clinical research, education, and adaptive technology development.
First Patients Treated with CyberKnife in Australia
First patients were treated in Melbourne, Australia using the CyberKnife system, improving access to radiation therapy and reducing the need for long-distance travel.
Service Revenue Growth
Service revenue for the quarter was $57 million, up 7% from the prior year, driven by contract revenue growth of 10% year-over-year.